These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20164006)

  • 41. Castleman's disease associated with pemphigus vulgaris.
    Gili A; Ngan BY; Lester R
    J Am Acad Dermatol; 1991 Nov; 25(5 Pt 2):955-9. PubMed ID: 1761779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cutaneous involvement as initial presentation of multicentric plasmacytic Castleman disease.
    Chen H; Ba W; Chen H; Yang H
    J Cutan Pathol; 2021 May; 48(5):701-705. PubMed ID: 33469928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular genetic, cytogenetic, and immunophenotypic analyses in Castleman's disease of the plasma cell type.
    Ohyashiki JH; Ohyashiki K; Kawakubo K; Serizawa H; Abe K; Mikata A; Toyama K
    Am J Clin Pathol; 1994 Mar; 101(3):290-5. PubMed ID: 8135184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Castleman's disease of the lacrimal gland.
    Koppens JM; Pon JA; Allen J; Sloan BH
    Clin Exp Ophthalmol; 2004 Feb; 32(1):108-10. PubMed ID: 14746606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease.
    Yoshizaki K; Matsuda T; Nishimoto N; Kuritani T; Taeho L; Aozasa K; Nakahata T; Kawai H; Tagoh H; Komori T
    Blood; 1989 Sep; 74(4):1360-7. PubMed ID: 2788466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Angiofollicular lymphatic hyperplasia with plasmacytoma and polyneuropathy: a case report with immunohistochemical study].
    Dworák O; Tschubel K; Zhou H; Meybehm M
    Klin Wochenschr; 1988 Jul; 66(13):591-5. PubMed ID: 3210655
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibrillary glomerulonephritis in Castleman's disease.
    Miadonna A; Salmaso C; Palazzi P; Elli A; Braidotti P; Lambertenghi Deliliers G
    Leuk Lymphoma; 1998 Jan; 28(3-4):429-35. PubMed ID: 9517516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multicentric Castleman's disease in a patient with primary Sjögren's syndrome.
    Tavoni A; Vitali C; Baglioni P; Gerli R; Marchetti G; Di Munno O; Bombardieri S
    Rheumatol Int; 1993; 12(6):251-3. PubMed ID: 8484099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Castleman disease. Histopathological and immunohistochemical analysis of 39 cases].
    Sevilla-Lizcano DB; Frias-Soria CL; Ortiz-Hidalgo C
    Gac Med Mex; 2017; 153(5):550-558. PubMed ID: 29099112
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comprehensive analysis of 225 Castleman's diseases in the oral maxillofacial and neck region: a rare disease revisited.
    He X; Wang Q; Wu Y; Hu J; Wang D; Qi B; Zhang W; Wang Y; Cheng J
    Clin Oral Investig; 2018 Apr; 22(3):1285-1295. PubMed ID: 28980074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A case of multicentric Castleman's disease demonstrating severe eosinophilia and enhanced production of interleukin-5.
    Ishii T; Tatekawa T; Koseto M; Ishii M; Kobayashi H; Koike M; Fujii T; Saeki Y
    Eur J Haematol; 2003 Feb; 70(2):115-8. PubMed ID: 12581193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multicentric Castleman's disease: imaging findings.
    Feldman DR; Schabel SI
    South Med J; 1996 Dec; 89(12):1159-61. PubMed ID: 8969348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Castleman's disease in childhood: report of three cases and review of the literature.
    Farruggia P; Trizzino A; Scibetta N; Cecchetto G; Guerrieri P; D'Amore ES; D'Angelo P
    Ital J Pediatr; 2011 Oct; 37():50. PubMed ID: 22014148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Castleman's disease.
    Shahidi H; Myers JL; Kvale PA
    Mayo Clin Proc; 1995 Oct; 70(10):969-77. PubMed ID: 7564550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease.
    Nishi J; Arimura K; Utsunomiya A; Yonezawa S; Kawakami K; Maeno N; Ijichi O; Ikarimoto N; Nakata M; Kitajima I; Fukushige T; Takamatsu H; Miyata K; Maruyama I
    Br J Haematol; 1999 Mar; 104(3):482-5. PubMed ID: 10086783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A case report of multicentric Castleman's disease with simultaneous Epstein-Barr virus infection.
    Yamac K; Senol E; Ataoglu O; Fen T
    Tumori; 2001; 87(5):343-5. PubMed ID: 11765188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Castleman's disease restricted to the infratemporal fossa.
    Rodrigo JP; Fernandez JA; Alvarez JC; Gómez J; Suárez C
    J Laryngol Otol; 1996 Sep; 110(9):896-8. PubMed ID: 8949309
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice.
    Screpanti I; Musiani P; Bellavia D; Cappelletti M; Aiello FB; Maroder M; Frati L; Modesti A; Gulino A; Poli V
    J Exp Med; 1996 Oct; 184(4):1561-6. PubMed ID: 8879230
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intestinal lymphangiectasia associated with angiofollicular lymph node hyperplasia (Castleman's disease).
    Moss SF; Thomas DM; Mulnier C; McGill IG; Hodgson HJ
    Gut; 1992 Jan; 33(1):135-7. PubMed ID: 1740268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunologic study of the hyaline-vascular type of Castleman's disease. A case study.
    Kimura H; Watanabe Y; Ohashi N; Kobayashi M; Asai M; Mizukoshi K
    Acta Otolaryngol Suppl; 1993; 504():146-50. PubMed ID: 8470523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.